IL13 and hepatocellular carcinoma: Innate lymphoid cells (ILCs) in the liver (ILC1, ILC2, ILC3 subsets) are less well studied in HCC, but ILC2 and ILC3 may contribute to the immunosuppressive cytokine milieu (IL-13, IL-22) that supports tumor growth [32,33].